Contemporary Management of Pineocytoma




Pineocytoma is a rare tumor; therefore, assimilating data from case reports and small case series to generate definitive treatment guidelines is difficult. The authors recently systematically reviewed the existing literature on outcomes for patients with pineocytoma. Gross total resection is associated with significantly increased tumor control and survival compared with subtotal resection combined with radiotherapy. When gross total resection is not possible, adding radiotherapy to subtotal resection is not associated with increases in either tumor control or survival. Although aggressive surgery in the pineal region carries the risk of neurologic injury, gross total resection should be attempted for pineocytoma.


Pineocytoma is a rare tumor, accounting for 0.4% to 1% of all intracranial tumors. The literature is primarily composed to case reports and small case series, occasionally with pineocytoma analyzed together with pineal region tumors of varying histology and behavior. Consequently, reported outcomes have traditionally varied, with tumor control rates ranging from 67% to 100%. These outcomes are based on a variety of treatment modalities, including aggressive resection, subtotal resection, radiotherapy, radiosurgery, or chemotherapy. Therefore, generating definitive treatment goals and guidelines has been difficult. The authors recently systematically reviewed the existing literature on pineocytoma to generate treatment recommendations based on specific outcomes. This review comprised 64 publications describing 168 patients.


Surgical debulking improves tumor control and survival


The pineal region harbors tumors of diverse pathology, and therefore obtaining a definitive tissue diagnosis is the initial goal of surgery. Open biopsy in generally preferred relative to stereotactic biopsy for tumors in this location. Because of the unique location of the pineal gland with respect to the vein of Galen as it receives the basal vein of Rosenthal, the internal cerebral, and the inferior occipital veins, the benefits of any open surgical procedure in this area must be weighted against risk to these critical deep venous structures. These structures will be encountered regardless of approach selection. The authors showed that, in the setting of pineocytoma, surgical resection reduced the overall reported rate of progression compared with biopsy (6.3% vs 17.8%; χ 2 P <.05). The 1- and 5-year progression-free survival rates for the surgical resection group versus the biopsy group were 97% versus 90%, and 89% versus 75%, respectively, which represented a statistically significant improvement on Kaplan-Meier analysis (log-rank, P <.05) ( Fig. 1 A). When comparing surgical resection versus biopsy, the 1- and 5-year overall survival rates were 89% versus 82%, and 76% versus 64%, respectively. Although the trend was toward improved survival with surgical resection, this difference did not reach statistical significance (log-rank, P = .19) (see Fig. 1 B). Thus, despite a suggestion of benefit, the data are insufficient to definitively conclude that surgical resection provides a survival benefit over a biopsy procedure combined with adjuvant therapy. Nevertheless, once committed to an open craniotomy to obtain a tissue diagnosis, tumor debulking should be attempted if the diagnosis is pineocytoma.




Fig. 1


Comparison of ( A ) progression-free survival and ( B ) overall survival among patients treated with surgical resection ( solid line ) versus biopsy ( dashed line ).




Gross total resection improves tumor control and survival


Aggressive surgery attempted in the pineal region carries the risk of devastating postoperative neurologic deterioration. Risk/benefit analyses based on outcomes data must be considered preoperatively. For the diagnosis of pineocytoma, no tumor recurrence was reported in patients who underwent gross total resection, which represented a significant improvement over patients receiving subtotal resection plus radiation (0% vs 9.5%, respectively; χ 2 P <.05). The 1- and 5-year progression-free survival rates for the surgical resection group versus the biopsy group was 100% versus 94%, and 100% versus 84%, respectively, which represented a statistically significant improvement on Kaplan-Meier analysis (log-rank, P <.05) ( Fig. 2 A). The 1- and 5-year overall survival rates for the gross total resection group versus the subtotal resection plus radiation (subtotal resection plus radiotherapy) group was 91% versus 88%, and 84% versus 17%, respectively. On Kaplan-Meier analysis, these differences represented a statistically significant improvement (log-rank, P <.05) (see Fig. 2 B). When compared with gross total resection, the addition of adjuvant radiotherapy to subtotal resection does not seem to provide an equivalent tumor control or survival outcome. Therefore, despite the difficult location of pineocytoma and the associated inherent surgical risks, aggressive resection should be undertaken, because gross total resection can be potentially curative.




Fig. 2


Comparison of ( A ) progression-free survival and ( B ) overall survival among patients treated with gross total resection ( solid line ) versus subtotal resection plus radiotherapy ( dashed line ).




Gross total resection improves tumor control and survival


Aggressive surgery attempted in the pineal region carries the risk of devastating postoperative neurologic deterioration. Risk/benefit analyses based on outcomes data must be considered preoperatively. For the diagnosis of pineocytoma, no tumor recurrence was reported in patients who underwent gross total resection, which represented a significant improvement over patients receiving subtotal resection plus radiation (0% vs 9.5%, respectively; χ 2 P <.05). The 1- and 5-year progression-free survival rates for the surgical resection group versus the biopsy group was 100% versus 94%, and 100% versus 84%, respectively, which represented a statistically significant improvement on Kaplan-Meier analysis (log-rank, P <.05) ( Fig. 2 A). The 1- and 5-year overall survival rates for the gross total resection group versus the subtotal resection plus radiation (subtotal resection plus radiotherapy) group was 91% versus 88%, and 84% versus 17%, respectively. On Kaplan-Meier analysis, these differences represented a statistically significant improvement (log-rank, P <.05) (see Fig. 2 B). When compared with gross total resection, the addition of adjuvant radiotherapy to subtotal resection does not seem to provide an equivalent tumor control or survival outcome. Therefore, despite the difficult location of pineocytoma and the associated inherent surgical risks, aggressive resection should be undertaken, because gross total resection can be potentially curative.




Fig. 2


Comparison of ( A ) progression-free survival and ( B ) overall survival among patients treated with gross total resection ( solid line ) versus subtotal resection plus radiotherapy ( dashed line ).




Adjuvant radiotherapy does not improve tumor control or survival


Limited data suggest a role for fractionated radiotherapy in pineocytoma management. Although the authors’ data show that gross total resection should be aggressively pursued to improve tumor control rates and extend survival, complete removal may not always be possible. In this setting, what is the role of adjuvant radiotherapy? In patients with pineocytoma, subtotal resection alone was associated with a similar rate of recurrence compared with treatment with subtotal resection plus radiotherapy (7.7% vs 11%; χ 2 P = .86). The 1- and 5-year progression-free survival rates for the subtotal resection groups versus the subtotal resection plus radiotherapy group were 100% and 94% (1-year), and 100% and 81% (5-year), respectively, which were not significantly different according to Kaplan-Meier analysis (log-rank, P = .83).


The 1- and 5-year overall survival rates for the subtotal resection group versus the subtotal resection plus radiotherapy group were 77% versus 88%, and 77% versus 17%, respectively. Although a trend was seen toward decreased overall survival in patients treated with subtotal resection plus radiotherapy, this difference was not statistically significant (log-rank, P = .14). These results suggest that postoperative adjuvant radiotherapy after subtotal resection does not significantly add to tumor control rates or survival compared with subtotal resection alone. Taken together with the inability of subtotal resection with radiotherapy to replace gross total resection, these results suggest that pineocytoma is a relative radioresistant lesion and, in the absence of better evidence suggesting radiotherapy is beneficial for this lesion, that conventional fractionated radiation treatment has a minimal role as either a sole or adjuvant treatment for pineocytoma. When evaluating a patient who has previously undergone a subtotal resection, repeat craniotomy with the goal of complete removal should be considered depending on surgeon comfort.




Summary


Based on the rarity of pineocytoma and the long follow-up required to adequately document recurrence and overall survival, a prospective trial to address management issues is unlikely. In the absence of these data, current evidence indicates that surgical resection is the appropriate treatment for these tumors. When anatomically possible, gross total resection should be attempted, because this is associated with improved tumor control and longer progression-free and overall survivals. Adjuvant fractionated radiotherapy does not improve rate of tumor control or survival when used to treat a subtotally resected tumor. If possible, future studies are needed to address issues related to postoperative neurovascular complications, particularly in patients who undergo gross total resection. Particular focus on preoperative variables such as tumor size, and operative technique such as patient position, will aid in surgical decision-making guidelines.


The authors have nothing to disclose.



References



  1. 1. Amendola B.E., Wolf A., Coy S.R., et al: Pineal tumors: analysis of treatment results in 20 patients. J Neurosurg 2005; 102: pp. 175-179

  2. 2. Kida Y., Kobayashi T., Tanaka T., et al: Radiosurgery for bilateral neurinomas associated with neurofibromatosis type 2. Surg Neurol 2000; 53: pp. 383-389

  3. 3. Linskey M.E., Lunsford L.D., and Flickinger J.C.: Radiosurgery for acoustic neurinomas: early experience. Neurosurgery 1990; 26: pp. 736-744

  4. 4. Deshmukh V.R., Smith K.A., Rekate H.L., et al: Diagnosis and management of pineocytomas. Neurosurgery 2004; 55: pp. 349-355

  5. 5. Hasegawa T., Kondziolka D., Hadjipanayis C.G., et al: The role of radiosurgery for the treatment of pineal parenchymal tumors. Neurosurgery 2002; 51: pp. 880-889

  6. 6. Jackson A.S., and Plowman P.N.: Pineal parenchymal tumours: I. Pineocytoma: a tumour responsive to platinum-based chemotherapy. Clin Oncol (R Coll Radiol) 2004; 16: pp. 238-243

  7. 7. Sakoda K., Uozumi T., Kawamoto K., et al: Responses of pineocytoma to radiation therapy and chemotherapy–report of two cases. Neurol Med Chir (Tokyo) 1989; 29: pp. 825-829

  8. 8. Clark A.J., Ivan M.E., Sughrue M.E., et al: Tumor control after surgery and radiotherapy for pineocytoma. J Neurosurg 2010; 113: pp. 319-324

  9. 9. Clark A.J., Sughrue M.E., Ivan M.E., et al: Factors influencing overall survival rates for patients with pineocytoma. J Neurooncol 2010; 100: pp. 255-260

  10. 10. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 35-1983. A 25-year-old woman with increasingly frequent headaches. N Engl J Med 1983; 309: pp. 542-549

  11. 11. Apuzzo M.L., Stieg P.E., Starr P., et al: Surgery of the Soul’s cistern. Neurosurgery 1996; 39: pp. 1022-1029

  12. 12. Barber S.G., Smith J.A., and Hughes R.C.: Melatonin as a tumour marker in a patient with pineal tumour. Br Med J 1978; 2: pp. 328

  13. 13. Bendersky M., Lewis M., Mandelbaum D.E., et al: Serial neuropsychological follow-up of a child following craniospinal irradiation. Dev Med Child Neurol 1988; 30: pp. 816-820

  14. 14. Borit A., Blackwood W., and Mair W.G.: The separation of pineocytoma from pineoblastoma. Cancer 1980; 45: pp. 1408-1418

  15. 15. D’Andrea A.D., Packer R.J., Rorke L.B., et al: Pineocytomas of childhood. A reappraisal of natural history and response to therapy. Cancer 1987; 59: pp. 1353-1357

  16. 16. Dario A., Cerati M., Taborelli M., et al: Cytogenetic and ultrastructural study of a pineocytoma case report. J Neurooncol 2000; 48: pp. 131-134

  17. 17. Dempsey P.K., Kondziolka D., and Lunsford L.D.: Stereotactic diagnosis and treatment of pineal region tumours and vascular malformations. Acta Neurochir (Wien) 1992; 116: pp. 14-22

  18. 18. Disclafani A., Hudgins R.J., Edwards M.S., et al: Pineocytomas. Cancer 1989; 63: pp. 302-304

  19. 19. Engel U., Gottschalk S., Niehaus L., et al: Cystic lesions of the pineal region—MRI and pathology. Neuroradiology 2000; 42: pp. 399-402

  20. 20. Fukushima T., Tomonaga M., Sawada T., et al: Pineocytoma with neuronal differentiation—case report. Neurol Med Chir (Tokyo) 1990; 30: pp. 63-68

  21. 21. Glanzmann C., and Seelentag W.: Radiotherapy for tumours of the pineal region and suprasellar germinomas. Radiother Oncol 1989; 16: pp. 31-40

  22. 22. Harada K., Hayashi T., Anegawa S., et al: Pineocytoma with intratumoral hemorrhage following ventriculoperitoneal shunt—case report. Neurol Med Chir (Tokyo) 1993; 33: pp. 836-838

  23. 23. Hazen S., Freiberg S.R., Thomas C., et al: Multiple distinct intracranial tumors: association of pinealoma and craniopharyngioma. Case report. Surg Neurol 1989; 31: pp. 381-386

  24. 24. Herrick M.K., and Rubinstein L.J.: The cytological differentiating potential of pineal parenchymal neoplasms (true pinealomas). A clinicopathological study of 28 tumours. Brain 1979; 102: pp. 289-320

  25. 25. Jooma R., and Kendall B.E.: Diagnosis and management of pineal tumors. J Neurosurg 1983; 58: pp. 654-665

  26. 26. Jouvet A., Saint-Pierre G., Fauchon F., et al: Pineal parenchymal tumors: a correlation of histological features with prognosis in 66 cases. Brain Pathol 2000; 10: pp. 49-60

  27. 27. Knierim D.S., and Yamada S.: Pineal tumors and associated lesions: the effect of ethnicity on tumor type and treatment. Pediatr Neurosurg 2003; 38: pp. 307-323

  28. 28. Kobayashi T., Kida Y., and Mori Y.: Stereotactic gamma radiosurgery for pineal and related tumors. J Neurooncol 2001; 54: pp. 301-309

  29. 29. Koide O., Watanabe Y., and Sato K.: Pathological survey of intracranial germinoma and pinealoma in Japan. Cancer 1980; 45: pp. 2119-2130

  30. 30. Kurisaka M., Arisawa M., Mori T., et al: Combination chemotherapy (cisplatin, vinblastin) and low-dose irradiation in the treatment of pineal parenchymal cell tumors. Childs Nerv Syst 1998; 14: pp. 564-569

  31. 31. Lee M.A., Leng M.E., and Tiernan E.J.: Risperidone: a useful adjunct for behavioural disturbance in primary cerebral tumours. Palliat Med 2001; 15: pp. 255-256

  32. 32. Linggood R.M., and Chapman P.H.: Pineal tumors. J Neurooncol 1992; 12: pp. 85-91

  33. 33. Mandera M., Marcol W., Bierzynska-Macyszyn G., et al: Pineal cysts in childhood. Childs Nerv Syst 2003; 19: pp. 750-755

  34. 34. Marcol W., Kotulska K., Grajkowska W., et al: Papillary pineocytoma in child: a case report. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2007; 151: pp. 121-123

  35. 35. Matsumoto K., Imaoka T., Tomita S., et al: Pineocytoma with massive intratumoral hemorrhage after ventriculoperitoneal shunt—case report. Neurol Med Chir (Tokyo) 1997; 37: pp. 911-915

  36. 36. Mawrin C., Grimm C., von Falkenhausen U., et al: Pineal epidermoid coinciding with pineocytoma. Acta Neurochir (Wien) 2003; 145: pp. 783-787

  37. 37. Mena H., Rushing E.J., Ribas J.L., et al: Tumors of pineal parenchymal cells: a correlation of histological features, including nucleolar organizer regions, with survival in 35 cases. Hum Pathol 1995; 26: pp. 20-30

  38. 38. Miles A., Tidmarsh S.F., Philbrick D., et al: Diagnostic potential of melatonin analysis in pineal tumors. N Engl J Med 1985; 313: pp. 329-330

  39. 39. Missori P., Delfini R., and Cantore G.: Tinnitus and hearing loss in pineal region tumours. Acta Neurochir (Wien) 1995; 135: pp. 154-158

  40. 40. Momozaki N., Ikezaki K., Abe M., et al: Cystic pineocytoma—case report. Neurol Med Chir (Tokyo) 1992; 32: pp. 169-171

  41. 41. Munoz M., and Page L.K.: Acquired double elevator palsy in a child with a pineocytoma. Am J Ophthalmol 1994; 118: pp. 810-811

  42. 42. Nakagawa H., Iwasaki S., Kichikawa K., et al: MR imaging of pineocytoma: report of two cases. AJNR Am J Neuroradiol 1990; 11: pp. 195-198

  43. 43. Nakamura M., Saeki N., Iwadate Y., et al: Neuroradiological characteristics of pineocytoma and pineoblastoma. Neuroradiology 2000; 42: pp. 509-514

  44. 44. Neuwelt E.A.: An update on the surgical treatment of malignant pineal region tumors. Clin Neurosurg 1985; 32: pp. 397-428

  45. 45. Neuwelt E.A., Buchan C., Blank N.K., et al: Surgical resection of a pineal tumor containing elements of germinoma and astrocytoma. Neurosurgery 1985; 16: pp. 373-378

  46. 46. Neuwelt E.A., Glasberg M., Frenkel E., et al: Malignant pineal region tumors. A clinico-pathological study. J Neurosurg 1979; 51: pp. 597-607

  47. 47. Packer R.J., Grossman R.I., Rorke L.B., et al: Brain stem necrosis after preradiation high-dose methotrexate. Childs Nerv Syst 1985; 1: pp. 355-358

  48. 48. Pople I.K., Athanasiou T.C., Sandeman D.R., et al: The role of endoscopic biopsy and third ventriculostomy in the management of pineal region tumours. Br J Neurosurg 2001; 15: pp. 305-311

  49. 49. Prahlow J.A., and Challa V.R.: Neoplasms of the pineal region. South Med J 1996; 89: pp. 1081-1087

  50. 50. Rainho C.A., Rogatto S.R., de Moraes L.C., et al: Cytogenetic study of a pineocytoma. Cancer Genet Cytogenet 1992; 64: pp. 127-132

  51. 51. Reyns N., Hayashi M., Chinot O., et al: The role of Gamma Knife radiosurgery in the treatment of pineal parenchymal tumours. Acta Neurochir (Wien) 2006; 148: pp. 5-11

  52. 52. Rubinstein L.J., and Okazaki H.: Gangliogliomatous differentiation in a pineocytoma. J Pathol 1970; 102: pp. 27-32

  53. 53. Schulder M., Liang D., and Carmel P.W.: Cranial surgery navigation aided by a compact intraoperative magnetic resonance imager. J Neurosurg 2001; 94: pp. 936-945

  54. 54. Schulte F.J., Herrmann H.D., Muller D., et al: Pineal region tumours of childhood. Eur J Pediatr 1987; 146: pp. 233-245

  55. 55. Shin E., Kim H., Kim T.S., et al: Pleomorphic variant of pineocytoma—a case report. Korean J Pathol 2004; 38: pp. 265-267

  56. 56. Shirane R., Shamoto H., Umezawa K., et al: Surgical treatment of pineal region tumours through the occipital transtentorial approach: evaluation of the effectiveness of intra-operative micro-endoscopy combined with neuronavigation. Acta Neurochir (Wien) 1999; 141: pp. 801-808

  57. 57. Steinbok P., Dolman C.L., and Kaan K.: Pineocytomas presenting as subarachnoid hemorrhage. Report of two cases. J Neurosurg 1977; 47: pp. 776-780

  58. 58. Tamaki N., and Yin D.: Therapeutic strategies and surgical results for pineal region tumours. J Clin Neurosci 2000; 7: pp. 125-128

  59. 59. Tracy P.T., Hanigan W.C., and Kalyan-Raman U.P.: Radiological and pathological findings in three cases of childhood pineocytomas. Childs Nerv Syst 1986; 2: pp. 297-300

  60. 60. Trojanowski J.Q., Tascos N.A., and Rorke L.B.: Malignant pineocytoma with prominent papillary features. Cancer 1982; 50: pp. 1789-1793

  61. 61. Tucker W.G., Leong A.S., and McCulloch G.A.: Tumours of the pineal region—neuroradiological aspects. Australas Radiol 1977; 21: pp. 313-324

  62. 62. Ueki K., and Tanaka R.: Treatments and prognoses of pineal tumors—experience of 110 cases. Neurol Med Chir (Tokyo) 1980; 20: pp. 1-26

  63. 63. Vaquero J., Coca S., Martinez R., et al: Papillary pineocytoma. Case report. J Neurosurg 1990; 73: pp. 135-137

  64. 64. Vaquero J., Ramiro J., Martinez R., et al: Clinicopathological experience with pineocytomas: report of five surgically treated cases. Neurosurgery 1990; 27: pp. 612-618

  65. 65. Vorkapic P., and Pendl G.: Microsurgery of pineal region lesions in children. Neuropediatrics 1987; 18: pp. 222-226

  66. 66. Vorkapic P., Waldhauser F., Bruckner R., et al: Serum melatonin levels: a new neurodiagnostic tool in pineal region tumors? Neurosurgery 1987; 21: pp. 817-824

  67. 67. Weisberg L.A.: Clinical and computed tomographic correlations of pineal neoplasms. Comput Radiol 1984; 8: pp. 285-292

  68. 68. Ziyal I.M., Sekhar L.N., Salas E., et al: Combined supra/infratentorial-transsinus approach to large pineal region tumors. J Neurosurg 1998; 88: pp. 1050-1057

  69. 69. Bruce J.N., and Ogden A.T.: Surgical strategies for treating patients with pineal region tumors. J Neurooncol 2004; 69: pp. 221-236

  70. 70. Kraichoke S., Cosgrove M., and Chandrasoma P.T.: Granulomatous inflammation in pineal germinoma. A cause of diagnostic failure at stereotaxic brain biopsy. Am J Surg Pathol 1988; 12: pp. 655-660

  71. 71. Chaynes P.: Microsurgical anatomy of the great cerebral vein of Galen and its tributaries. J Neurosurg 2003; 99: pp. 1028-1038

  72. 72. Youssef AS, Downes AE, Agazzi S, et al. Life without the vein of Galen: clinical and radiographic sequelae. Clin Anat, in press. DOI:10.1002/ca.21176.

  73. 73. Lekovic G.P., Gonzalez L.F., Shetter A.G., et al: Role of Gamma Knife surgery in the management of pineal region tumors. Neurosurg Focus 2007; 23: pp. E12

  74. 74. Dandy W.E.: Operative experience in cases of pineal tumor. Arch Surg 1936; 33: pp. 19-46

  75. 75. Stoiber E.M., Schaible B., Herfarth K., et al: Long term outcome of adolescent and adult patients with pineal parenchymal tumors treated with fractionated radiotherapy between 1982 and 2003—a single institution’s experience. Radiat Oncol 2010; 5: pp. 122

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Oct 13, 2017 | Posted by in NEUROSURGERY | Comments Off on Contemporary Management of Pineocytoma

Full access? Get Clinical Tree

Get Clinical Tree app for offline access